About Hans Keirstead
Hans Keirstead is a chairman at Immunis.
Hans Keirstead first appears on SEC filings in 2024.
Experience
This experience comes from Hans Keirstead's profile and from SEC filings. For roles taken from filings, the years are when the filings name Hans Keirstead in the role, so the role may have started earlier or lasted longer.
CO
Chief Executives Organization Current
Member
2023 – Present
RV
RDiscovery Ventures Current
Chairman of the Board
2022 – Present
NA
National Institute of Child Sexual Assault Current
Chairman of the Board of Directors
2021 – Present
PI
Praxis Spinal Cord Institute Current
Member of the Board of Advisors
2020 – Present
UR
UCI Chief Executive Roundtable Current
Board Member
2020 – Present
Immunis, Inc. Current
Chairman of the Board
2019 – Present · Irvine, CA
Develops investigational therapies for people with age-related muscle and metabolic diseases.
ZP
Zero Abuse Project Current
Board Member
2019 – Present
AI
AIVITA Biomedical, Inc. Current
Chairman and Chief Executive Officer
2016 – Present
YO
YPO - Young Presidents' Organization Current
Member
2010 – Present
HP
Human Immunome Project
Chief Executive Officer
2023 – 2025
MP
Mission Plasticos
Board Member
2021 – 2025
AF
ALEXANDRA GUCCI CHILDREN’S FOUNDATION
Board Member
2020 – 2022
CO
CEO Leadership Alliance Orange County (CLA-OC)
Member
2020 – 2022
UV
UCI Law School Board of Visitors
Board Member
2019 – 2022
PL
Plasticos
Vice Chair
2018 – 2021
CB
Caladrius Biosciences
Chief Science Officer & Senior Vice President
2014 – 2016
UI
University of California, Irvine
Professor of Anatomy and Neurobiology, Professor of Neurological Surgery
2000 – 2015
CI
California Stem Cell, Inc.
CEO and President
2006 – 2014
Key Colleagues at Startups
The people Hans Keirstead works with at each company, as listed on that company's latest Form D.
Immunis, Inc. · Form D, Jun 15, 2026
